ArticleActa neuropathologica2019
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Sven J van der Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
72 papers cite itlatest 60 shown
this papercites it